Medical News

RSS

BARDA awards contract to develop Pfenex Expression Technology

Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA) has awarded Pfenex a contract providing for up to a total of $18.8 million in funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government. The contract will support the development of a robust Pfenex Expression Technology based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax.

4 Aug 2010

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add 9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB). The decision could also leave thousands of patients dependent on others to help them take their insulin, says DTB, which today launches its "Don't Drop Mixtard 30" campaign to convince the company to change its mind.

4 Aug 2010

Administration touts Medicare savings report; Republicans complain it misleads seniors

A report issued Monday by the Obama administration found that the new health care law "will save Medicare $8 billion by the end of 2011, and $575 billion over the next decade, largely by improving care quality and preventing waste and fraud." The report also predicts that the overhaul will "extend the life of the program more than a decade.

4 Aug 2010

Celera decreases second-quarter net loss to $6.1 million

Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.

4 Aug 2010

Bayshore Home Health announces acquisition of CCT

Bayshore Home Health announced today the purchase of Windsor, Ontario-based home health care company Community Care Therapy Limited. The acquisition expands Bayshore's home care service offerings to include occupational therapy, physiotherapy and speech language pathology.

4 Aug 2010

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

SGI, a global leader in HPC and data center solutions, today announced that the Queensland Centre for Medical Genomics at the University of Queensland has selected SGI LiveArc storage solution to increase its ability to store, manage and process human cancer genome sequence data. This project will contribute to mapping the genetic changes that lead to cancer, providing better understanding of such cancers and potentially helping to combat the disease.

4 Aug 2010

New health law is uncharted terrain for administration, insurers

The White House pressured insurers to begin covering kids with pre-existing conditions as soon as the health overhaul law was enacted, The New York Times reports. But after a few months, some insurers decided to stop offering "child only" plans altogether to minimize their losses. The give-and-take resulted in the White House saying insurers could limit enrollment to specific periods last week.

4 Aug 2010

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector.

4 Aug 2010

Cancer cells utilize fructose as an alternative to glucose for fueling growth: Study

A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.

4 Aug 2010

American Medical Systems second-quarter net income increases 22.0% to $20.6M

American Medical Systems Holdings, Inc. reported sales of $136.4 million for the second quarter of 2010, a 7.9 percent increase over sales of $126.4 million in the comparable quarter of 2009. Adjusting for the negative impact of $1.4 million due to fluctuations in foreign exchange rates since the time the second quarter guidance was issued; revenue would have achieved the upper end of the guidance range.

4 Aug 2010

Smokefree enters joint venture with Colorado to market smoke-free pharmacological products

Smokefree Innotec, Inc. Thomas Schroepfer, CEO, announced today that the Company has executed a Joint venture agreement with a Colorado research and development corporation focusing on natural holistic and herbal medical compounds, operating out of laboratory facilities located in Colorado Springs. The business objective is to jointly develop and market several smoke-free high tech natural and herbal pharmacological products, initially based upon an oral delivery system utilizing the innovative technology developed for the "REAL Smokefree Cigarette". Under this joint venture Smokefree Innotec, Inc. will provide its smoke-free products and devices, and its venture partner will provide all the medical extract formulations to the Company.

4 Aug 2010

Children's hospitals, other medical centers now eligible for discounted drugs in Medicaid

The Hill: "Children's hospitals and other medical centers on Monday became eligible to enroll in a Medicaid program that offers discounted drugs, as called for in the healthcare reform law.

4 Aug 2010

$CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL$

CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL

Cell Therapeutics, Inc. today announced it has filed for a Special Protocol Assessment ("SPA") with the U.S. Food and Drug Administration ("FDA") for the design of its new phase III trial of pixantrone for patients with relapsed or refractory aggressive B-Cell non-Hodgkin's lymphoma ("NHL").

4 Aug 2010

Study solves puzzle behind different types of skin cancer on different body parts

A consistent all-over tan may be impossible to achieve because some body areas are much more resistant to tanning than others, a study has found.Researchers - funded by the Medical Research Council (MRC) - at the University of Edinburgh say the results explain why some holidaymakers find it so hard to achieve an even tan all over their body.

4 Aug 2010

WebMD second-quarter adjusted EBITDA increases 71% to $34.3 million

WebMD Health Corp., the leading source of health information, today announced financial results for the three months ended June 30, 2010.

4 Aug 2010

Premier international conference to discuss latest diagnostic tools, emerging therapies for personalized medicine

What As scientists understand more about a tumor's underlying biology, personalized medicine is emerging as the new patient management paradigm. This year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and industry to discuss the latest in diagnostic tools and emerging therapies.

4 Aug 2010

New York lawmakers trying to revive 9/11 health care bill

Lawmakers are trying to bridge the gap between colleagues on the left and right in a bid to provide greater health coverage for 9/11 workers, The Wall Street Journal reports. "The bill was voted down [in the House] late Thursday night amid angry partisan finger-pointing, and now Democratic Rep. Carolyn Maloney and others have begun weighing options to make the bill more tolerable to factions on the right and left. … Already, Democrats are signaling a shift in strategy.

4 Aug 2010

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.

4 Aug 2010

International conference to discuss research, unresolved issues of sickle cell disease

Carlton Haywood Jr., Ph.D., an associate faculty member of the Johns Hopkins Berman Institute of Bioethics, will mark the 100-year anniversary of the discovery of sickle cell anemia on Wednesday, Aug. 4, with a talk on the impact that race has had on the history of research and treatment of the inherited blood disorder.

4 Aug 2010

RehabCare second-quarter consolidated operating revenues increase 62.8% to $334.0 million

RehabCare Group, Inc. today reported financial results for the quarter and six months ended June 30, 2010. Comparative results for the quarter and six months follow.

4 Aug 2010

Medical News

BARDA awards contract to develop Pfenex Expression Technology

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

Administration touts Medicare savings report; Republicans complain it misleads seniors

Celera decreases second-quarter net loss to $6.1 million

Bayshore Home Health announces acquisition of CCT

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

New health law is uncharted terrain for administration, insurers

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

Cancer cells utilize fructose as an alternative to glucose for fueling growth: Study

American Medical Systems second-quarter net income increases 22.0% to $20.6M

Smokefree enters joint venture with Colorado to market smoke-free pharmacological products

Children's hospitals, other medical centers now eligible for discounted drugs in Medicaid

CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL

Study solves puzzle behind different types of skin cancer on different body parts

WebMD second-quarter adjusted EBITDA increases 71% to $34.3 million

Premier international conference to discuss latest diagnostic tools, emerging therapies for personalized medicine

New York lawmakers trying to revive 9/11 health care bill

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

International conference to discuss research, unresolved issues of sickle cell disease

RehabCare second-quarter consolidated operating revenues increase 62.8% to $334.0 million

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News